Elorza, Anabel L.
HRN: 06-32-28 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2024
CEFTRIAXONE 1G (VIAL)
02/03/2024
02/09/2024
IV
2g
OD
CAP MR
Waiting Final Action